Fan FT et al[18] also found that EGFR-activated nuclear PKM2 could increase β-catenin transactivation in liver cancer cells, promoting the transcriptional expression of its target genes and participating in the EMT process of liver cancer cells. This evidence concerns the gene PKM and liver cancer.